Scott Taylor, MD
Physical Medicine & Rehabilitation · New Castle, INNPI 1871539148
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (52.6%), speaking fees and travel and lodging — rather than concentrated in one kind of arrangement. 29 manufacturers reported payments, led by Boston Scientific at 58.7% of the total. Reporting peaked in 2021 at $6,400 and has fallen 80.0% since, to $1,279 in 2025. Among physical medicine & rehabilitation clinicians in IN with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 300 payments — averaging $59.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$10K
- Abbott$4K
- Medtronic$978
- Nevro Corp.$608
- Vertos Medical, Inc.$486
- Pacira Therapeutics, Inc.$362
- plus $1K from 23 others
Across 3 payments — averaging $196.73 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$590
What the payments were for
- Speaking & faculty fees$7,65043%
- Travel & lodging$8055%
- Food & beverage$9,39053%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 79 | $10,473 |
| Abbott | 100 | $3,781 |
| Medtronic(2 entities) | 33 | $978 |
| Nevro Corp. | 16 | $608 |
| Vertos Medical, Inc. | 5 | $486 |
| Pacira Therapeutics, Inc. | 16 | $362 |
| MML US, Inc. | 4 | $293 |
| Bioventus LLC | 6 | $109 |
| GSK | 7 | $96 |
| Pfizer | 4 | $68 |
| AbbVie(2 entities) | 4 | $64 |
| Vertiflex, Inc. | 2 | $55 |
| Spinal Simplicity, LLC | 1 | $50 |
| Averitas Pharma Inc. | 2 | $47 |
| Ironshore Pharmaceuticals Inc. | 3 | $45 |
| Amgen | 3 | $45 |
| Vertex | 2 | $41 |
| GRT US Holding, Inc. | 2 | $40 |
| Sanofi-aventis U.S. LLC | 1 | $31 |
| Sanofi Pasteur Inc. | 1 | $27 |
| Globus Medical | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $17 |
| Neos Therapeutics, LP | 1 | $17 |
| Johnson & Johnson | 1 | $17 |
| Nalu Medical, Inc. | 1 | $15 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
| Avanos Medical | 1 | $15 |
| Supernus Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SUPERION$7,939
- PROCLAIM$672
- Neuromodulation Dspsbls and Accs$581
- Proclaim IPG$511
- WaveWriter Alpha Prime 16$403
- mild Device Kit$391
- Senza Spinal Cord Stimulation System$275
- GENERAL PAIN MANAGEMENT$257
- INTELLIS ADAPTIVESTIM$220
- ReActiv8$157
- Prodigy Family of SCS IPGs$138
- VECTRIS$128
- SPECTRA WAVEWRITER$124
- Proclaim Family of SCS IPGs$124
- WAVEWRITER ALPHA$122
- GENERAL - THERAPIES$113
How this compares
$17,845 in reported general payments places this provider in the 95th percentile of 140 physical medicine & rehabilitation providers in Indiana.
See all physical medicine & rehabilitation providers in Indiana →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 23 | $1,167 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 99 | $961 |
| Gabapentin | 51 | $422 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 14 | $296 |
| Cyclobenzaprine Hcl | 17 | $176 |
| Tramadol Hcl | 30 | $134 |
| Methylprednisolone | 14 | $57 |
| Tizanidine Hcl | 16 | $52 |
Paid to pharmacies, not to this prescriber.
Other physical medicine & rehabilitation in New Castle
- Andrew DavissonNew Castle$74K
- Christina WalzFort Wayne$503K
- Shashank DaveIndianapolis$198K
- Sayed WaheziFort Wayne$161K
- Sachin MehtaIndianapolis$60K
- David StenslandFort Wayne$24K
- Jeffrey BeckTerre Haute$10K
- Daniel RothFort Wayne$10K
- Anthony MimmsIndianapolis$10K
- Flora HammondIndianapolis$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.